VanEck Biotech ETF
BBH
115 hedge funds and large institutions have $161M invested in VanEck Biotech ETF in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 32 reducing their positions, and 14 closing their positions.
1.4% more ownership
Funds ownership: 31.43% → 32.83% (+1.4%)
3% more capital invested
Capital invested by funds: $156M → $161M (+$5.16M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 120 → 115 (-5)
13% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 32
14% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Miller Investment Management
West Conshohocken,
Pennsylvania
|
+$16.3M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.72M |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
+$1.08M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$994K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KAS
Kestra Advisory Services
Austin,
Texas
|
-$2.58M |
| 2 |
LJAC
L.J. Altfest & Co
New York
|
-$2.28M |
| 3 |
JP Morgan Chase
New York
|
-$2.08M |
| 4 |
TAM
Tocqueville Asset Management
New York
|
-$1.97M |
| 5 |
BIM
Bullseye Investment Management
Cincinnati,
Ohio
|
-$1.78M |
BBH Hedge Fund Activity: Q1 2023 in Review
115 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2023, worth a combined $161M — up 3.3% from $156M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of BBH and 12 opened new positions — a net loss of 2 holders — while 32 trimmed existing stakes and 28 added.
The largest buyer was Miller Investment Management, adding an estimated $16.3M. The largest seller was Kestra Advisory Services, cutting an estimated $2.58M.
- 115 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2023, down from 120 in Q4 2022.
- Funds reported $161M of VanEck Biotech ETF stock for Q1 2023, up 3.3% quarter-over-quarter.
- 12 funds opened new VanEck Biotech ETF positions in Q1 2023 and 14 closed out, a net change of -2 holders.
- The largest VanEck Biotech ETF buyer in Q1 2023 was Miller Investment Management, an estimated $16.3M added.
- The largest VanEck Biotech ETF seller in Q1 2023 was Kestra Advisory Services, an estimated $2.58M sold.
Based on aggregated 13F filings for Q1 2023.